Regencell Bioscience Holdings Ltd
RGC$2.98B
Mid CapNASDAQMedicinal Chemicals & Botanical Products🇺🇸North AmericaHONG KONG10 employees
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Next month
Market Overview
Stock performance and key metrics
RGC News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
No drugs found in this phase.
📑
→Catalyst DossierPRO
The full research note — thesis, the if-approved scenario, financials & smart money. Compiled by CeliA.
Catalyst Verdict
Full breakdown — the signals behind the verdict
Market-Implied Move
Regulatory Approvals
Frequently asked questions
When is Regencell Bioscience Holdings Ltd's next FDA catalyst?→
Regencell Bioscience Holdings Ltd's (RGC) next tracked catalyst is a Earnings expected October 30, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track RGC biotech catalysts?→
Add RGC to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Regencell Bioscience Holdings Ltd's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply